More articles from Research Watch

G9a Inhibition Has Antitumor Activity in Bladder Cancer
Cancer Discovery Jul 2019, DOI: 10.1158/2159-8290.CD-RW2019-105
Structural Analysis of Smoothened Reveals a Sterol Binding Site
Cancer Discovery Jul 2019, DOI: 10.1158/2159-8290.CD-RW2019-106
A C19MC–LIN28A–MYCN Oncogenic Circuit Drives a Pediatric Brain Cancer
Cancer Discovery Jul 2019, DOI: 10.1158/2159-8290.CD-RW2019-107
Some Mutational Hotspots May Be APOBEC3A-Associated Passengers
Cancer Discovery Jul 2019, DOI: 10.1158/2159-8290.CD-RW2019-102
Pediatric Cancers with Low Mutation Burden Can Be Immunogenic
Cancer Discovery Jul 2019, DOI: 10.1158/2159-8290.CD-RW2019-103
Mutations in FOXA1 Cluster into Distinct Structural and Phenotypic Classes
Cancer Discovery Jul 2019, DOI: 10.1158/2159-8290.CD-RW2019-101
A KIR3DL2 Antibody Is Safe and Active in Cutaneous T-cell Lymphoma
Cancer Discovery Jul 2019, DOI: 10.1158/2159-8290.CD-RW2019-104
Identification and Characterization of a Musculin Mutant in Lymphoma
Cancer Discovery Jul 2019, 9 (7) 827; DOI: 10.1158/2159-8290.CD-RW2019-082
KMT9 Is an Epigenetic Writer That Controls Prostate Cancer Cell Growth
Cancer Discovery Jul 2019, 9 (7) 824; DOI: 10.1158/2159-8290.CD-RW2019-074
Tumor-Initiating Stem Cells Are Resistant to Immunotherapy
Cancer Discovery Jul 2019, 9 (7) 823; DOI: 10.1158/2159-8290.CD-RW2019-066

Main menu